NCT03988764Recruiting
Monogenic Diabetes Misdiagnosed as Type 1
Accurate Diagnosis of Diabetes for Appropriate Management
Source: ClinicalTrials.gov · Last updated 10 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 11 Jun 2019
- Start date
- 24 Sept 2019
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT03988764
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 24 Sept 2019 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Existing T1D autoantibody testing with a positive result
Who the study is looking for
- Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type.
Age in the registry: 1 day to 25 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Montreal Children's Hospital Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.